We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Technology Developed for Tissue Engineering

By LabMedica International staff writers
Posted on 05 Oct 2009
Researchers have received a U.S. More...
grant to develop a novel bioreactor system that will control the mechanoelectrochemical environment for tissue growth and also provide on-line monitoring for the properties of engineered tissues.

The two-year, US$735,000 grant from the U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health (NIH; Bethesda, MD, USA), will provide funding for the University of Miami (UM) College of Engineering (FL, USA). The grant will fund the work of Drs. Weiyong Gu and Charles Huang, professors in the department of biomedical engineering, to develop the novel bioreactor system for engineering tissue in vitro for implantation in vivo.

"Congratulations to Dr. Gu and Dr. Huang for being awarded such a prestigious grant on behalf of the College of Engineering,” stated Dean James M. Tien, Ph.D., NAE. "Funding from the NIH/NIBIB serves the college and university, and also opens lines of inquiry and exploration about how technology can be applied to reengineering the human body, a key focus of the College's research thrusts,” added Dr. Tien.

Tissue engineering research aims to develop functional substitutes for diseased or damaged tissues. In order to succeed, the mechanoelectrochemical environment in tissue culture needs to be optimized. "The new bioreactor system will provide innovative technology for tissue engineering, thus facilitating the development of functional replacement tissues that can be used in repairing damaged tissue, such as cartilage and intervertebral discs,” stated Dr. Huang.

There are two stages to the proposed project. The first stage will be to design and develop the bioreactor system and the second will evaluate the system. This technology will help scientists understand the mechanisms of tissue growth and tissue degeneration. "The broad, long-term objectives of the work are to elucidate the causes of intervertebral disc degeneration, to develop strategies for restoring tissue function or retarding further disc degeneration and to develop novel, less-invasive diagnostic tools for disc degeneration,” said Dr. Gu.

The grant provides an invaluable opportunity for undergraduate and graduate students in the College of Engineering to work hands-on with essential research and development in biomedical imaging and bioengineering, according to the researchers.

Related Links:
National Institute of Biomedical Imaging and Bioengineering
University of Miami College of Engineering



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.